Skip to main content
HYEX
OTC Life Sciences

Healthy Extracts Raises $459,500 Net via 13% Secured Convertible Note With 12.5% Revenue Royalty

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.351
Mkt Cap
$19.919M
52W Low
$0.805
52W High
$4.25
52W Position info
68% above low
Off High info
68% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

HYEX sits 68% above its 52-week low of $0.805.

Summary

Healthy Extracts raised $459,500 net through a $555,556 secured convertible note paying 13% interest and 12.5% of gross revenue from March 2027, secured by substantially all company assets. For a company with $143,267 on hand, the cash buys runway at a high cost and with restrictive covenants.


Key Events · Financing and Capital Events · HYEX

  • Secured Convertible Note Closed

    On November 10, 2026 the company issued a $555,556 secured promissory note to Hinterland Partners LLC with a $55,556 original issue discount, 13% annual interest and a 30-month maturity.

  • Net Proceeds of $459,500

    The company received $459,500 after the holder withheld $5,500 for legal fees, $5,000 for due diligence and $30,000 for placement agent Carter, Terry & Company.

  • 12.5% Revenue Royalty From March 2027

    Beginning March 1, 2027 the company must pay 12.5% of the prior month's gross revenue monthly until the note is extinguished, applied first to accrued interest and then principal.

  • All Assets Pledged as Collateral

    A security agreement grants the holder a security interest in substantially all assets of the company and its subsidiaries, terminating automatically on a NASDAQ, NYSE or NYSE American listing.


Analysis · HYEX · Life Sciences

Healthy Extracts is funding itself with a small, expensive secured note rather than equity, a choice that matters given the $143,267 of cash against $9.17 million of current liabilities reported in its November 16 10-Q. On a $555,556 face amount, the company nets $459,500 after a $55,556 original issue discount and roughly $40,500 of fees, pays 13% interest, and pledges substantially all assets of the company and its subsidiaries. The royalty is the costly part: from March 1, 2027 it must hand over 12.5% of gross revenue every month until the note is gone, which on a business with roughly $619,000 of quarterly revenue is a meaningful claim on cash. Conversion at a fixed $2.00 is far above today's $1.35 price, so near-term dilution from conversion is unlikely unless the stock recovers; the real risk is the default trigger, where the conversion price falls to 75% of the lowest recent traded price and the balance jumps to 150%. The note also blocks variable-rate financings for 18 months and gives the holder participation and most-favored-nation rights, narrowing future financing options.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HYEX was trading at $1.35 on OTC in the Life Sciences sector, with a market capitalization of approximately $19.9M. The 52-week trading range was $0.81 to $4.25. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HYEX - Latest Insights

HYEX
Nov 16, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.35
Real-time Price: $1.35 info
Change: $0 (0%) info
Market Cap: $19.919M info
HYEX
Nov 16, 2026, 4:05 PM EST
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $1.35
Real-time Price: $1.35 info
Change: $0 (0%) info
Market Cap: $19.919M info
HYEX
Aug 14, 2026, 7:41 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.35
Real-time Price: $1.35 info
Change: +$0.0012 (+0.09%) info
Market Cap: $19.919M info
HYEX
Aug 14, 2026, 5:29 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.35
Real-time Price: $1.35 info
Change: +$0.0012 (+0.09%) info
Market Cap: $19.919M info
HYEX
Aug 06, 2026, 8:42 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.39
Real-time Price: $1.35 info
Change: -$0.0388 (-3%) info
Market Cap: $19.919M info